FDA Panel: Expand Use of Fish Oil Drug Vascepa
Research shows drug can reduce rates of dangerous cardiovascular events in high-risk patients.
Research shows drug can reduce rates of dangerous cardiovascular events in high-risk patients.
Subsequent risk for CV events lower among patients with ischemic stroke, TIA, evidence of atherosclerosis who target a low-density lipoprotein (LDL) cholesterol level of less than 70 mg/dL.
A history of kidney stones among patients undergoing percutaneous coronary intervention is associated with higher in-hospital mortality and 1- and 3-year myocardial infarctions risks.
In a study, serum bicarbonate levels less than 22 mEq/L were associated with an increased incidence of major adverse cardiovascular events.
In population-based sample, CKD linked to increased risk for MI, composite cardiovascular outcome.
Authors say efforts to maintain normal blood pressure may cut cardiovascular disease.
The FDA has granted Fast Track designation to ASP1128, an investigational treatment for patients at increased risk of developing moderate to severe acute kidney injury (AKI) after coronary artery bypass and/or valve (CABG/V) surgery.
Amount of alcohol intake per drinking session was not associated with new-onset atrial fibrillation.
Patients routinely taking antihypertensive meds at bedtime have lower risk for CV events, death
In 2017, 27.3 percent of CVD deaths occurred in the hospital, while 30.9 percent occurred at home